EE242 Cost-Effectiveness Analysis of Entrectinib for Treatment NTRK Fusion-Positive Tumors in Czech Republic
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.490
https://www.valueinhealthjournal.com/article/S1098-3015(22)02694-8/fulltext
Title :
EE242 Cost-Effectiveness Analysis of Entrectinib for Treatment NTRK Fusion-Positive Tumors in Czech Republic
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02694-8&doi=10.1016/j.jval.2022.09.490
First page :
Section Title :
Open access? :
No
Section Order :
10019